Pleco Therapeutics: Funding, Investors & Team (Sep 2026)
Pleco Therapeutics is a pharmaceutical manufacturing company that provides pre-clinical development programs for cancer treatment.
Pleco Therapeutics has raised $17.1M across 1 funding round on record, the most recent a Series A of $17.1M announced in Sep 2022.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Pleco Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2022.
Pleco Therapeutics Funding Rounds
Pleco Therapeutics Founders and Leadership Team
Contact details for the Pleco Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Pleco Therapeutics Funding Compared to Other Health Care Startups
Pleco Therapeutics' latest round of $17.1M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pleco Therapeutics in Health Care and Nijmegen
Companies Similar to Pleco Therapeutics
The most cutting-edge polymer-based platform of restorative cardiovascular devices was created by Xeltis.…
Vitestro revolutionizes the way patients are cared for by introducing independent blood-drawing technology.
ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and…
Speaklee is a company that utilizes AI technology to create a speech assistant tool for children who have…
CardiacBooster is a company in the medical field that creates percutaneous devices to assist the left…
Plasmacure offers a patented cold plasma solution designed to heal chronic wounds. They provide services in…
Hy2Care® is a company that originated from the MIRA Institute at the University Twente in the Netherlands, a…
Platos Health is a technology startup dedicated to increasing access to preventive healthcare. Our current…
AVIGI Therapeutics is leading the way in creating new drugs through a rational approach that combines…
Sirius medical helps in improving healthcare for cancer patients by developing medical devices that helps in…
PROBLEM Insufficient treatment of vulnerable plaque in the coronary arteries lead to costly and health…
Pleco Therapeutics Funding FAQs
What does Pleco Therapeutics do?
Pleco Therapeutics is a pharmaceutical manufacturing company that provides pre-clinical development programs for cancer treatment.
How much funding has Pleco Therapeutics raised?
Pleco Therapeutics has raised $17.1M across 1 round on record. The most recent is a Series A of $17.1M announced in Sep 2022.
When did Pleco Therapeutics last raise funding?
Pleco Therapeutics' most recent funding round on record is a Series A of $17.1M, announced in Sep 2022.
Who founded Pleco Therapeutics?
FundedIQ lists Dan Gelvan (Founder) at Pleco Therapeutics.
Where is Pleco Therapeutics headquartered?
Pleco Therapeutics is based in Nijmegen, Gelderland, Netherlands.
How many employees does Pleco Therapeutics have?
Pleco Therapeutics is in the 1-10 employee band.
How does Pleco Therapeutics' funding compare to other Health Care startups?
Pleco Therapeutics' latest round of $17.1M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Pleco Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pleco Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.